KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to $53.9 million.

  • Emergent BioSolutions' Shares Outstanding (Weighted Average) rose 150.66% to $53.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $53.9 million, marking a year-over-year increase of 150.66%. This contributed to the annual value of $53.0 million for FY2024, which is 351.56% up from last year.
  • According to the latest figures from Q3 2025, Emergent BioSolutions' Shares Outstanding (Weighted Average) is $53.9 million, which was up 150.66% from $54.3 million recorded in Q2 2025.
  • In the past 5 years, Emergent BioSolutions' Shares Outstanding (Weighted Average) registered a high of $54.4 million during Q1 2025, and its lowest value of $50.1 million during Q4 2022.
  • For the 5-year period, Emergent BioSolutions' Shares Outstanding (Weighted Average) averaged around $52.3 million, with its median value being $52.6 million (2024).
  • As far as peak fluctuations go, Emergent BioSolutions' Shares Outstanding (Weighted Average) plummeted by 651.77% in 2022, and later soared by 421.46% in 2025.
  • Over the past 5 years, Emergent BioSolutions' Shares Outstanding (Weighted Average) (Quarter) stood at $53.5 million in 2021, then dropped by 6.36% to $50.1 million in 2022, then grew by 2.2% to $51.2 million in 2023, then grew by 3.52% to $53.0 million in 2024, then increased by 1.7% to $53.9 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $53.9 million in Q3 2025, compared to $54.3 million in Q2 2025 and $54.4 million in Q1 2025.